Certican

Certican (Everolimus) is an oral medication used to prevent organ rejection after transplants. This immunosuppressant helps manage the body's immune response, supporting transplant success.

Certican (Everolimus) is primarily used to prevent organ rejection in patients who have undergone liver or kidney transplants. It works by suppressing the immune system's response to the new organ, reducing the risk of rejection. This medication is often part of a broader treatment plan that includes other immunosuppressants and careful monitoring by healthcare professionals.

Common effects of Certican (Everolimus) may include headaches, nausea, and fatigue. Some users also report mild digestive issues or changes in blood pressure. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Certican (Everolimus) should be handled with care, especially by those with liver or kidney conditions. Regular blood tests are often recommended to monitor organ function. It is important to follow the guidance of a healthcare professional when using this medication.

Certican (Everolimus) may interact with certain medications, including some antibiotics, antifungals, and other immunosuppressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and grapefruit products should also be avoided as they can affect how the body processes this medication.